PT - JOURNAL ARTICLE AU - Hannah Krystal TI - The Misclassification of Medical Marijuana AID - 10.29158/JAAPL.003790-18 DP - 2018 Dec 01 TA - Journal of the American Academy of Psychiatry and the Law Online PG - 472--479 VI - 46 IP - 4 4099 - http://jaapl.org/content/46/4/472.short 4100 - http://jaapl.org/content/46/4/472.full SO - J Am Acad Psychiatry Law2018 Dec 01; 46 AB - Marijuana has a complicated legal, social, and economic history in the United States, as well as an uncertain future. Marijuana has been consistently tied to racial minority groups since its arrival in the United States in the 1900s, and former Attorney General Jeff Sessions further propagated that notion. AG Sessions even recently wrote a memo that directly contradicted Obama-era policy, demonstrating that the current legal status of marijuana in both state and federal government is currently up for debate. While several states have legalized marijuana for medical or even recreational purposes, federal law still categorizes cannabis as a drug with no currently accepted medical use and a high potential for abuse. The comparison between marijuana, opioids, and ketamine in this article demonstrates that marijuana has been unnecessarily withheld and stigmatized by the federal government. Also reviewed is the impact of stringent marijuana-based legal policies upon the racial makeup of prison populations. The implications of current policy upon potential and future research are also discussed, with the determination that current policy has stymied research and prevented a more accurate determination of the risks and benefits of medical marijuana.